<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000661183">
  <TermName>phosphonoformate trisodium</TermName>
  <TermPronunciation>(FOS-foh-noh-FOR-mayt try-SOH-dee-um)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A drug used to treat infections with herpesviruses in people whose immune systems are weakened by AIDS. It blocks the viruses from making copies of themselves. It is a type of antiviral agent. Also called foscarnet sodium and Foscavir.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000726329" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;phosphonoformate trisodium&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000726328" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;fosfonoformato trisódico&quot;" language="es" id="_4"/>
  <SpanishTermName>fosfonoformato trisódico</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Medicamento que se usa para el tratamiento de las infecciones por virus del herpes en personas cuyo sistema inmunitario está debilitado por el SIDA. Impide que los virus hagan copias de sí mismos.   Es un tipo de antivírico. También se llama foscarnet sódico y Foscavir.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2010-03-30</DateFirstPublished>
</GlossaryTerm>
